4.8 Editorial Material

Stem Cells and DNA Damage: Persist or Perish?

期刊

CELL
卷 142, 期 3, 页码 360-362

出版社

CELL PRESS
DOI: 10.1016/j.cell.2010.07.030

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL

Praveen Anand, Amy Guillaumet-Adkins, Valeriya Dimitrova, Huiyoung Yun, Yotam Drier, Noori Sotudeh, Anna Rogers, Madhu M. Ouseph, Monica Nair, Sayalee Potdar, Randi Isenhart, Jake A. Kloeber, Tushara Vijaykumar, Leili Niu, Tiffaney Vincent, Guangwu Guo, Julia Frede, Marian H. Harris, Andrew E. Place, Lewis B. Silverman, David T. Teachey, Andrew A. Lane, Daniel J. DeAngelo, Jon C. Aster, Bradley E. Bernstein, Jens G. Lohr, Birgit Knoechel

Summary: By conducting full-length single-cell RNA sequencing, we identified two highly distinct stem-like states in early T-cell progenitor acute lymphoblastic leukemia (ETP-ALL), which differed significantly in terms of cell cycle and oncogenic signaling, as well as dependence on Notch activation and PI3K signaling. Our study revealed complex interactions between signaling programs, cellular plasticity, and immune programs in ETP-ALL, highlighting the multidimensionality of tumor heterogeneity.
Article Oncology

Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis

Katsuhiro Togami, Sun Sook Chung, Vikas Madan, Christopher A. G. Booth, Christopher M. Kenyon, Lucia Cabal-Hierro, Justin Taylor, Sunhee S. Kim, Gabriel K. Griffin, Mahmoud Ghandi, Jia Li, Yvonne Y. Li, Fanny Angelot-Delettre, Sabeha Biichle, Michael Seiler, Silvia Buonamici, Scott B. Lovitch, Abner Louissaint, Elizabeth A. Morgan, Fabrice Jardin, Pier Paolo Piccaluga, David M. Weinstock, Peter S. Hammerman, Henry Yang, Marina Konopleva, Naveen Pemmaraju, Francine Garnache-Ottou, Omar Abdel-Wahab, H. Phillip Koeffler, Andrew A. Lane

Summary: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive leukemia primarily occurring in males, and the mutations in X chromosome gene ZRSR2 are associated with impaired dendritic cell function and predisposition to leukemic transformation.

CANCER DISCOVERY (2022)

Article Cell Biology

AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia

Adrien Grenier, Laury Poulain, Johanna Mondesir, Arnaud Jacquel, Claudie Bosc, Lucille Stuani, Sarah Mouche, Clement Larrue, Ambrine Sahal, Rudy Birsen, Victoria Ghesquier, Justine Decroocq, Fetta Mazed, Mireille Lambert, Mamy Andrianteranagna, Benoit Viollet, Patrick Auberger, Andrew A. Lane, Pierre Sujobert, Didier Bouscary, Jean-Emmanuel Sarry, Jerome Tamburini

Summary: AMPK activation in AML cells triggers the unfolded protein response, leading to repression of oxidative phosphorylation, TCA cycle, and pyrimidine biosynthesis, as well as enhanced mitochondrial apoptotic signaling. Combination therapy with the AMPK activator GSK621 and the Bcl-2 inhibitor venetoclax shows synergistic effects, suggesting therapeutic potential in AML.

CELL REPORTS (2022)

Article Dermatology

Shared Clonal Origin of Multiple Histiocytic and Dendritic Neoplasms and Polycythemia Vera, Follicular Lymphoma in 1 Patient

Cecilia Larocca, Vignesh Shanmugam, David Zemmour, Joseph H. H. Antin, Andrew A. A. Lane

AMERICAN JOURNAL OF DERMATOPATHOLOGY (2022)

Article Oncology

Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax

Evan C. Chen, Yiwen Liu, Courtney E. Harris, Eric S. Winer, Martha Wadleigh, Andrew A. Lane, Rahul S. Vedula, R. Coleman Lindsley, Kevin M. Copson, Anne Charles, Francisco Marty, Donna Neuberg, Daniel J. DeAngelo, Richard M. Stone, Marlise R. Luskin, Nicolas C. Issa, Jacqueline S. Garcia

Summary: The use of antifungal prophylaxis does not appear to provide benefits for newly diagnosed AML patients receiving VEN/HMA treatment, especially in institutions with low incidence of fungal infections.

LEUKEMIA & LYMPHOMA (2022)

Article Biotechnology & Applied Microbiology

Mitochondrial variant enrichment from high-throughput single-cell RNA sequencing resolves clonal populations

Tyler E. Miller, Caleb A. Lareau, Julia A. Verga, Erica A. K. DePasquale, Vincent Liu, Daniel Ssozi, Katalin Sandor, Yajie Yin, Leif S. Ludwig, Chadi A. El Farran, Duncan M. Morgan, Ansuman T. Satpathy, Gabriel K. Griffin, Andrew A. Lane, J. Christopher Love, Bradley E. Bernstein, Vijay G. Sankaran, Peter van Galen

Summary: The combination of single-cell transcriptomics and mitochondrial DNA variant detection is useful for establishing lineage relationships in primary human cells, but current methods are not suitable for analyzing complex tissues. In this study, researchers combined common 3' single-cell RNA-sequencing protocols with mitochondrial transcriptome enrichment to significantly increase coverage and enable high-confidence mutation detection. This method successfully identified skewed immune cell expansions in primary human clonal hematopoiesis.

NATURE BIOTECHNOLOGY (2022)

Article Multidisciplinary Sciences

Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells

Tianyu Cai, Agnes Gouble, Kathryn L. Black, Anna Skwarska, Ammar S. Naqvi, Deanne Taylor, Ming Zhao, Qi Yuan, Mayumi Sugita, Qi Zhang, Roman Galetto, Stephanie Filipe, Antonio Cavazos, Lina Han, Vinitha Kuruvilla, Helen Ma, Connie Weng, Chang-Gong Liu, Xiuping Liu, Sergej Konoplev, Jun Gu, Guilin Tang, Xiaoping Su, Gheath Al-Atrash, Stefan Ciurea, Sattva S. Neelapu, Andrew A. Lane, Hagop Kantarjian, Monica L. Guzman, Naveen Pemmaraju, Julianne Smith, Andrei Thomas-Tikhonenko, Marina Konopleva

Summary: This study demonstrates that UCART123 has selective anti-tumor activity against CD123-positive BPDCN cells, and exhibits strong efficacy in vitro and in mouse models.

NATURE COMMUNICATIONS (2022)

Article Immunology

Single-Cell Multiomics Reveals Clonal T-Cell Expansions and Exhaustion in Blastic Plasmacytoid Dendritic Cell Neoplasm

Erica A. K. DePasquale, Daniel Ssozi, Marina Ainciburu, Jonathan Good, Jenny Noel, Martin A. Villanueva, Charles P. Couturier, Alex K. Shalek, Sary F. Aranki, Hari R. Mallidi, Gabriel K. Griffin, Andrew A. Lane, Peter van Galen

Summary: The immune system plays a major role in inhibiting cancer progression, and the study of immunoregulatory interactions between malignant cells and T-cells in BPDCN provides valuable insights. By analyzing single-cell transcriptomes, it was observed that T-cells in BPDCN patients upregulate IFNA response and downregulate TNFA pathways, indicating T-cell exhaustion and immune evasion mechanisms in BPDCN.

FRONTIERS IN IMMUNOLOGY (2022)

Review Oncology

CD123 and More: How to Target the Cell Surface of Blastic Plasmacytoid Dendritic Cell Neoplasm

Elodie Bole-Richard, Naveen Pemmaraju, Blandine Cael, Etienne Daguindau, Andrew A. Lane

Summary: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia derived from plasmacytoid dendritic cells (pDCs). Recently, the first-in-class CD123-targeting therapy, tagraxofusp, was approved for treatment of BPDCN. Other CD123-targeting strategies are in development, including bispecific antibodies and combination approaches with tagraxofusp and other novel agents. Adoptive T-cell therapy using chimeric antigen receptor (CAR)-modified T cells represents a promising new avenue in immunotherapy. This article discusses novel and innovative therapies in development to target surface molecules in BPDCN and explores potential future treatment options.

CANCERS (2022)

Article Hematology

Peripheral blood CD3+ T-cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignancies

Geoffrey Fell, Ashley E. Rosko, Gregory A. Abel, Clark Dumontier, Kelly J. Higby, Anays Murillo, Donna S. Neuberg, Christin E. Burd, Andrew A. Lane

Summary: Older patients with cancer may benefit from targeted treatment based on their frailty status, but currently there is a lack of quantitative biomarkers for assessing frailty. In this study, researchers identified four gene expressions in T cells that were associated with frailty in patients with haematological malignancies. A regression model based on these gene expressions showed high sensitivity and specificity for identifying robust patients. These findings suggest potential biomarkers for future frailty assessment.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Oncology

Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

Naveen Pemmaraju, Kendra L. Sweet, Anthony S. Stein, Eunice S. Wang, David A. Rizzieri, Sumithira Vasu, Todd L. Rosenblat, Christopher L. Brooks, Nassir Habboubi, Tariq Mughal, Hagop Kantarjian, Marina Konopleva, Andrew A. Lane

Summary: In this article, the long-term results of a clinical trial for BPDCN, including treatment-naive and relapsed/refractory patients, were reported. The study showed that TAG monotherapy resulted in high and durable responses in first-line patients with BPDCN, allowing many patients to bridge to stem-cell transplant.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Letter Oncology

Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN)

James A. Davis, David A. Rizzieri, Andrew A. Lane, Justin Taylor, Muhammad Salman Faisal, Sumithira Vasu, Deborah Soong, Hong Li, Amanda Herbst, I. Brian Greenwell

LEUKEMIA & LYMPHOMA (2022)

Letter Hematology

Genomics of PDGFR-rearranged hypereosinophilic syndrome

Esther Rheinbay, Meifang Qi, Juliette M. Bouyssou, Andrew J. Oler, Lauren Thumm, Michelle Makiya, Irina Maric, Amy D. Klion, Andrew A. Lane

BLOOD ADVANCES (2023)

Editorial Material Hematology

DDX41: here, there ... and everywhere

Christopher R. Reilly, Andrew A. Lane

Summary: In this study, Cheloor Kovilakam et al conducted a comprehensive population-level analysis of >450,000 adults in the UK Biobank to assess the epidemiological characteristics, clinical features, and malignancy risk associated with germ line pathogenic variants in the DEAD box RNA helicase 41 gene (DDX41-GPV).
Article Medicine, Research & Experimental

Expansion, persistence, and efficacy of donor memory- like NK cells infused for posttransplant relapse

Roman M. Shapiro, Grace C. Birch, Guangan Hu, Juliana Vergara Cadavid, Sarah Nikiforow, Joanna Baginska, Alaa K. Ali, Mubin Tarannum, Michal Sheffer, Yasmin Z. Abdulhamid, Benedetta Rambaldi, Yohei Arihara, Carol Reynolds, Max S. Halpern, Scott J. Rodig, Nicole Cullen, Jacquelyn O. Wolff, Kathleen L. Pfaff, Andrew A. Lane, R. Coleman Lindsley, Corey S. Cutler, Joseph H. Antin, Vincent T. Ho, John Koreth, Mahasweta Gooptu, Haesook T. Kim, Karl-Johan Malmberg, Catherine J. Wu, Jianzhu Chen, Robert J. Soiffer, Jerome Ritz, Rizwan Romee

JOURNAL OF CLINICAL INVESTIGATION (2022)

暂无数据